Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer
Open Access
- 1 September 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (17), 5332-5340
- https://doi.org/10.1158/1078-0432.ccr-08-1033
Abstract
Purpose: We examined the presence of the pregnane X receptor (PXR) and its effects on ovarian cancer cells after activation by its cognate ligand. Experimental Design: SKOV-3 and OVCAR-8 ovarian carcinoma cells were analyzed for expression of PXR by quantitative reverse transcription-PCR and Western blot. Human ovarian cancer tissue was also analyzed for PXR expression by immunochemistry. Ligand (agonist)–induced PXR target genes were analyzed in SKOV-3 cells by quantitative reverse transcription-PCR. SKOV-3 cell proliferation was assessed by MTT assay. In vivo confirmation of in vitro effects of PXR ligands were done in NOD.SCID mice carrying SKOV-3 xenografts. Results: PXR is expressed in ovarian cancer cells. In SKOV-3 cells, PXR is functional and its activation by cognate ligands induces PXR target genes (CYP2B6, CYP3A4, and UGT1A1) but not MDR1 and MRP2. PXR activation in SKOV-3 cells induces cell proliferation and drug resistance. In mice harboring SKOV-3 xenografts, rifampicin (PXR agonist) induces cell proliferation and tumor growth. Conclusion: PXR activation, regardless of the type of ligand agonist present, promotes the “malignant” phenotype of cancer cells. These data serve as the basis for finding novel nontoxic inhibitors of PXR activation as a method to control cell growth and prevent induction of drug resistance.Keywords
This publication has 34 references indexed in Scilit:
- Activated Pregnenolone X-Receptor Is a Target for Ketoconazole and Its AnalogsClinical Cancer Research, 2007
- T0901317 is a potent PXR ligand: Implications for the biology ascribed to LXRFEBS Letters, 2007
- Crystal structure of the PXR–T1317 complex provides a scaffold to examine the potential for receptor antagonismBioorganic & Medicinal Chemistry, 2007
- Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell linesCancer, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Orphan Nuclear Receptor Constitutive Active/Androstane Receptor–Mediated Alterations in DNA Methylation during Phenobarbital Promotion of Liver TumorigenesisToxicological Sciences, 2006
- Identification of Genes Controlled by the Pregnane X Receptor by Microarray Analysis of mRNAs from Pregnenolone 16 -Carbonitrile-Treated RatsToxicological Sciences, 2006
- Expression of the Steroid and Xenobiotic Receptor and Its Possible Target Gene, Organic Anion Transporting Polypeptide-A, in Human Breast CarcinomaCancer Research, 2006
- A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell linesInvestigational New Drugs, 2005
- A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor ActivityPublished by Elsevier BV ,2005